Found: 10
Select item for more details and to access through your institution.
Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma.
- Published in:
- 2023
- By:
- Publication type:
- Letter
An open‐label, prospective trial to evaluate the efficacy and safety of ixazomib in combination with cyclophosphamide and dexamethasone in patients with newly diagnosed POEMS syndrome.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 2, p. 478, doi. 10.1111/bjh.19626
- By:
- Publication type:
- Article
CAR‐T cell therapy targeting B cell maturation antigen is effective for relapsed/refractory multiple myeloma, including cases with poor performance status.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 933, doi. 10.1002/ajh.26583
- By:
- Publication type:
- Article
The Landscape of Cytogenetic Aberrations in Light-Chain Amyloidosis with or without Coexistent Multiple Myeloma.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 4, p. 1624, doi. 10.3390/jcm12041624
- By:
- Publication type:
- Article
Single‐cell RNA‐seq reveals clonal diversity and prognostic genes of relapsed multiple myeloma.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 3, p. 1, doi. 10.1002/ctm2.757
- By:
- Publication type:
- Article
Elevated serum levels of soluble B-cell maturation antigen as a prognostic biomarker for multiple myeloma.
- Published in:
- Clinical & Experimental Immunology, 2024, v. 217, n. 3, p. 221, doi. 10.1093/cei/uxae043
- By:
- Publication type:
- Article
Plasma Cell-free DNA chromosomal instability score as early predictor to monitor tumor burden in response to therapeutic in multiple myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e63, doi. 10.1016/j.clml.2019.09.098
- By:
- Publication type:
- Article
A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02276-7
- By:
- Publication type:
- Article
A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02276-7
- By:
- Publication type:
- Article
Dysregulated circular RNAs are closely linked to multiple myeloma prognosis, with circ_0026652 predicting bortezomib-based treatment response and survival via the microRNA-608-mediated Wnt/β-catenin pathway.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8410
- By:
- Publication type:
- Article